The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
The study’s authors, led by Marin Schrappe, MD, of Christian Albrechts University Kiel and University Hospital Schleswig-Holstein in Germany, enrolled pediatric patients with
The combination of iberdomide, a novel cereblon E3 ligase modulator, with daratumumab and dexamethasone improved rates of minimal residual disease–negative complete response compared
The authors, led by Nicolas Boissel, MD, PhD, of Hôpital Saint-Louis in Paris, France, analyzed 94 patients with high-risk B-ALL who received up
The analysis, led by Hannah Goulart, MD, of The University of Texas MD Anderson Cancer Center in Houston Texas, was presented at the
The study, led by Elias Jabbour, MD, of The University of Texas MD Anderson Cancer Center in Houston, was presented at the Fourteenth
ae H Park, MD, of Memorial Sloan Kettering Cancer Center in New York, and colleagues presented the findings at the Fourteenth Annual Meeting
Amifostine and uproleselan also showed “meaningful promise” for reducing mucositis and delaying severe diarrhea and improving GI quality of life, respectively, but require
The study, led by Ashutosh Wechalekar, MD, of National Amyloidosis Centre and University College London Hospitals in the United Kingdom, analyzed a combined
Final results from the first-in-human phase 1 study of arlo-cel represent the longest follow-up with GPRC5D CAR T-cell therapy in relapsed or refractory
The study, led by Raúl Azibeiro Melchor, of Hospital Universitario de Salamanca in Spain, will be presented at the Fourteenth Annual Meeting of
